At New Health Montana, patients suffering from chronic mental illness receive relief from symptoms thanks to ketamine. The team at the clinic knows that low-dose ketamine can result in real life-changing results for many patients. Some conditions they treat include depression, PTSD, and anxiety.
The team at New Health Montana prides themselves on their attentive care, comfortable environment, and welcoming atmosphere. By giving their patients a safe place to receive care, they provide dramatic healing.
Research has shown that ketamine for depression is effective in roughly 70 percent of patients. With mental health issues on the rise, the staff at the Missoula clinic wants to help as many people as possible using this breakthrough ketamine therapy.
– IV ketamine infusion therapy
Ketamine has a bit of stigma and baggage given its history. While you may think of it as a “party drug” from the 1990s, there is a growing amount of research that says it has some positive potential. The more research our major institutions conduct, the less stigma there will be around these drugs. And if they can help people with drug-resistant depression, anxiety, PTSD, etc, then why wouldn’t we put these to use in proper, clinical settings?
This is primarily due to its stigma as a party drug. The truth is yes, ketamine is legal. In fact, it is only a Schedule III drug by the DEA. This puts it on the same level as Tylenol and codeine. So don’t let the baggage of this drug stop you from learning more about it. As always, ask your doctor if ketamine therapy is right for you.
Ketamine IV infusion therapy is the most common form of ketamine treatment. The drug is administered directly into the bloodstream through an intravenous drip into the arm. During the treatment, the patient lies still in a calm setting. The effect is usually immediate and can last weeks.
Patients typically receive a series of six infusions over two to three weeks. Typically, most treatments last, on average, two hours. This is what’s called the “induction phase” of the treatment. A doctor monitors the patient’s response to the treatment. The patient stops treatment if the first phase is not effective. The patient moves onto the “maintenance phase” if he or she shows signs of improvement.
At this stage patients typically return for one infusion every two to six weeks. At this point, the treatment can last as long as the patient desires and shows improvement.